EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH CRYOPYRIN ASSOCIATED PERIODIC SYNDROMES: AN OPEN-LABEL, PHASE-III, EXTENSION STUDY

被引：4
|
作者：
Brogan, P. A. [1 ,2 ]
Hofer, M. [3 ]
Kuemmerle-Deschner, J. B. [4 ]
Lauwerys, B. [5 ,6 ]
Speziale, A. [7 ]
Leon, K. [8 ]
Wei, X. [9 ]
Laxer, R. [10 ]
机构：
[1] UCL Inst Child Hlth, Dept Infect Inflammat & Rheumatol, London, England
[2] Great Ormond St Hosp NHS Fdn Trust, London, England
[3] Hosp Univ Vaudois, Unite Romande Rhumatol Pediat, Lausanne, Switzerland
[4] Univ Hosp Tuebingen, Tubingen, Germany
[5] Clin Univ St Luc, Brussels, Belgium
[6] Catholic Univ Louvain, Brussels, Belgium
[7] Novartis Pharma AG, Basel, Switzerland
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Novartis Pharmaceut, Beijing, Peoples R China
[10] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.4865
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0503
引用
收藏
页码：620 / 621
页数：2
相关论文
共 50 条
  • [31] An Open-Label Extension Study Evaluating the Long-Term Safety and Efficacy of Romiplostim in Thrombocytopenic Patients (Pts) with Myelodysplastic Syndromes (MDS).
    Fenaux, Pierre
    Kantarjian, Hagop
    Lyons, Roger
    Larson, Richard A.
    Sekeres, Mikkael A.
    Becker, Pamela S.
    Muus, Petra
    Hu, Kuolong
    Berger, Dietmar
    Franklin, Janet L.
    BLOOD, 2009, 114 (22) : 1081 - 1081
  • [32] Safety and efficacy of duloxetine in Japanese patients with chronic knee pain due to osteoarthritis: an open-label, long-term, Phase III extension study
    Uchio, Yuji
    Enomoto, Hiroyuki
    Ishida, Mitsuhiro
    Tsuji, Toshinaga
    Ochiais, Toshimitsu
    Konno, Shinichi
    JOURNAL OF PAIN RESEARCH, 2018, 11 : 1391 - 1403
  • [33] Safety and Efficacy of Epratuzumab in an Open-Label Extension Study (SL0006)
    Hobbs, K.
    Wallace, D. J.
    Strand, V.
    Kalunian, K.
    Kilgallen, B.
    Bongardt, S.
    Wegener, W. A.
    Goldenberg, D. M.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S276 - S277
  • [34] Safety and efficacy of aceneuramic acid in GNE myopathy: open-label extension study
    Suzuki, Naoki
    Mori-Yoshimura, Madoka
    Katsuno, Masahisa
    Takahashi, Masanori P.
    Yamashita, Satoshi
    Oya, Yasushi
    Hashizume, Atsushi
    Yamada, Shinichiro
    Nakamori, Masayuki
    Izumi, Rumiko
    Kato, Masaaki
    Warita, Hitoshi
    Tateyama, Maki
    Kuroda, Hiroshi
    Asada, Ryuta
    Yamaguchi, Takuhiro
    Nishino, Ichizo
    Aoki, Masashi
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (11): : 1093 - 1094
  • [35] Efficacy and safety of rilonacept (Interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes
    Hoffman, Hal M.
    Throne, Martin L.
    Amar, N. J.
    Sebai, Mohamed
    Kivitz, Alan J.
    Kavanaugh, Arthur
    Weinstein, Steven P.
    Belomestnov, Pavel
    Yancopoulos, George D.
    Stahl, Neil
    Mellis, Scott J.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (08): : 2443 - 2452
  • [36] An Open-Label, Phase III Study to Assess the Efficacy and Safety of Cysteamine Ophthalmic Solution 0.55% in Japanese Cystinosis Patients
    Goi, Nobuhiro
    Iwata, Fumino
    Sugihara, Yoko
    Higa, Shingo
    Chikama, Taiichiro
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 3457 - 3471
  • [37] Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III
    Suhler, Eric B.
    Adan, Alfredo
    Brezin, Antoine P.
    Fortin, Eric
    Goto, Hiroshi
    Jaffe, Glenn J.
    Kaburaki, Toshikatsu
    Kramer, Michal
    Lim, Lyndell L.
    Muccioli, Cristina
    Quan Dong Nguyen
    Van Calster, Joachim
    Cimino, Luca
    Kron, Martina
    Song, Alexandra P.
    Liu, Jianzhong
    Pathai, Sophia
    Camez, Anne
    Schlaen, Ariel
    van Velthoven, Mirjam E. J.
    Vitale, Albert T.
    Zierhut, Manfred
    Tari, Samir
    Dick, Andrew D.
    OPHTHALMOLOGY, 2018, 125 (07) : 1075 - 1087
  • [38] 3-years Safety and Efficacy Outcomes of Canakinumab Treatment in Cryopyrin-associated Periodic Syndromes (CAPS) - Data from the RELIANCE Registry
    Kuemmerle-Deschner, Jasmin B.
    Kortus-Goetze, Birgit
    Oommen, Prasad T.
    Janda, Ales
    Rech, Juergen
    Schuetz, Catharina
    Kallinich, Tilmann
    Weller-Heinemann, Frank
    Horneff, Gerd
    Foeldvari, Ivan
    Meier, Florian
    Borte, Michael
    Krickau, Tobias
    Weber-Arden, Julia
    Blank, Norbert
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1613 - 1614
  • [39] Efficacy and Safety of Abatacept in Patients with Early Active Primary Sjogren's Syndrome - Open-label Extension Phase of a Randomized Controlled Phase III Trial
    van Nimwegen, Jolien
    Mossel, Esther
    Wijnsma, Robin
    van Zuiden, Greetje
    Delli, Konstantina
    Stel, Alja
    van der Vegt, Bert
    Haacke, Erlin
    Olie, Lisette
    Los, Leonie
    Verstappen, Gwenny
    Pringle, Sarah
    Spijkervet, Fred
    Kroese, Frans
    Vissink, Arjan
    Arends, Suzanne
    Bootsma, Hendrika
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [40] Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treatment Extension Study
    Brunner, Hermine, I
    Quartier, Pierre
    Alexeeva, Ekaterina
    Constantin, Tamas
    Kone-Paut, Isabelle
    Marzan, Katherine
    Schneider, Rayfel
    Wulffraat, Nico M.
    Chasnyk, Vyacheslav
    Tirosh, Irit
    Kallinich, Tilmann
    Kuemmerle-Deschner, Jasmin
    Wouters, Carine
    Lauwerys, Bernard
    Nikishina, Irina
    Trachana, Maria
    Vougiouka, Olga
    Martini, Alberto
    Lovell, Daniel J.
    Levy, Jeremy
    Vritzali, Eleni
    Ruperto, Nicolino
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (12) : 2147 - 2158
12345